Kiora Pharmaceuticals, Inc. Stock Analysis & AI Score
Kiora Pharmaceuticals, Inc. (KPRX) has an ST Score of 57.6 (B-), driven by its Momentum (A+) and held back by its Profitability (C). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Kiora Pharmaceuticals, Inc. (KPRX) has an ST Score of 57.6 (B-), driven by its Momentum (A+) and held back by its Profitability (C). Analysts rate it Buy.
- Strongest
- MomentumA+
- Weakest
- ProfitabilityC
All factor grades
- MomentumA+
- Financial StrengthB+
- GrowthB
- ValuationB-
- ProfitabilityC
- Piotroski2/9
Contact
KPRX stock: frequently asked questions
What is KPRX's ST Score?
Kiora Pharmaceuticals, Inc. (KPRX) has an ST Score of 57.6 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KPRX a buy, hold, or sell?
Analysts rate KPRX a Buy. Our ST Score grades it B- (57.6/100). The ST Score is a data-driven signal, not a recommendation.
What are KPRX's factor grades?
Valuation B-, Profitability C, Financial Strength B+, Momentum A+, Growth B.
What is KPRX's valuation grade?
Kiora Pharmaceuticals, Inc. (KPRX) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KPRX's growth grade?
Kiora Pharmaceuticals, Inc. (KPRX) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KPRX's profitability grade?
Kiora Pharmaceuticals, Inc. (KPRX) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KPRX's financial strength grade?
Kiora Pharmaceuticals, Inc. (KPRX) earns a financial strength grade of B+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is KPRX's Piotroski score?
Kiora Pharmaceuticals, Inc. (KPRX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.